XML 63 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Share Capital, Warrants and Options (Details Narrative)
3 Months Ended
Aug. 31, 2020
CAD ($)
$ / shares
shares
Aug. 13, 2020
CAD ($)
$ / shares
shares
Mar. 31, 2021
CAD ($)
Option
Int
$ / shares
shares
Mar. 31, 2020
CAD ($)
Option
$ / shares
shares
Mar. 23, 2021
shares
Dec. 31, 2020
CAD ($)
shares
Issue of Equity [Line items]            
Share capital issued through exercise of warrants     $ 665,000      
Share capital issued through exercise of warrants, shares | shares          
Common stock, share issued | shares         251,000  
Expected dividend yield     0.00% 0.00%    
Risk-free interest rate     0.93% 1.21%    
Expected volatility     127.83% 121.55%    
Eligible exploration expenditures     $ 39,168,000     $ 39,103,000
Trade payables     7,500      
Transfer to deficit for expired options and warrants     97,953 $ 199,971    
Expense from share-based payment transactions on grant of options     837,444 884,247    
Transfer to common share capital for expired warrants     $ 242,901    
Stock Option Plan [Member]            
Issue of Equity [Line items]            
Period of options granted     5 years 5 years    
Number of stock option granted | Option     3,185,000 6,650,000    
Stock options exercisable price per share | $ / shares     $ 0.32 $ 0.16    
Maximum [Member]            
Issue of Equity [Line items]            
Percentage of beneficially owns, issued and outstanding     10.00%      
Number of votes per share at meeting of holders of preference shares | Int     1      
Period from date of issuance when shares become convertible     6 months      
Period of notice to convert shares     10 days      
Period of options granted     10 years      
Non Brokered Private Placement [Member]            
Issue of Equity [Line items]            
Warrant description Each warrant will entitle the holder to acquire one common share of the Company at an exercise price of $0.09 for a period of 24 months from its date of issuance. The warrants are subject to an acceleration clause such that if the closing market price of the common shares on the TSX-V is greater than $0.12 per common share for a period of 10 consecutive trading days at any time after the four-month anniversary of the closing of the placement, the Company may, at its option, accelerate the warrant expiry date to within 30 days.          
Share issuance costs in cash $ 124,222          
Finder's fee paid in common share purchase warrant | shares 588,154          
Exercise price of warrant | $ / shares $ 0.09          
Fair value of warrants issued $ 716,055          
Expected life 2 years          
Expected dividend yield 0.00%          
Non Brokered Private Placement [Member] | Maximum [Member]            
Issue of Equity [Line items]            
Risk-free interest rate 0.28%          
Expected volatility 158.00%          
Non Brokered Private Placement [Member] | Minimum [member]            
Issue of Equity [Line items]            
Risk-free interest rate 0.31%          
Expected volatility 158.53%          
Non Brokered Private Placement [Member] | Agent's Warrants [Member]            
Issue of Equity [Line items]            
Fair value of warrants issued $ 18,547          
Non Brokered Private Placement [Member] | First Tranche [Member]            
Issue of Equity [Line items]            
Number of units issued | shares   15,481,077        
Price of unit issued | $ / shares   $ 0.07        
Total gross proceeds   $ 1,083,675        
Non Brokered Private Placement [Member] | Second And Final Tranche [Member]            
Issue of Equity [Line items]            
Number of units issued | shares 5,661,780          
Price of unit issued | $ / shares $ 0.07          
Total gross proceeds $ 396,325          
Series 1 Convertible Preferred Shares [Member]            
Issue of Equity [Line items]            
Authorized capital | shares     100,000,000      
Par value per share | $ / shares          
Common Stock [Member]            
Issue of Equity [Line items]            
Share capital issued through exercise of warrants, shares | shares     6,278,219      
Common stock, share issued | shares     116,111,867 88,690,791   109,833,648
Common stock, shares outstanding | shares     116,111,867 88,690,791   109,833,648
Share capital     $ 90,534,000     $ 89,627,000
Series 1 Preferred Shares [Member]            
Issue of Equity [Line items]            
Common stock, shares outstanding | shares     590,931 590,931    
Preferred Stock [Member]            
Issue of Equity [Line items]            
Share capital     $ 591,000     $ 591,000
Conversion value of share | $ / shares     $ 1      
Factor by which number of shares on conversion is calculated | $ / shares     $ 9.00